Anti-PD-1/PD-L1 therapy is an immunotherapy that blocks the interaction between PD-1 and PD-L1 to restore the killing function of T cells against tumor cells and thus inhibit the growth and spread of tumors. Here, PDCD1 is linked to neoplasm.